Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

MJW McPate; RS. Duncan; JC Hancox; HJ Witchel

Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

MJW McPate, RS. Duncan, JC Hancox, HJ Witchel

School of Physiology, Pharmacology & Neuroscience

Research output: Contribution to journal › Article (Academic Journal) › peer-review

92 Citations (Scopus)

Translated title of the contribution	Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs
Original language	English
Pages (from-to)	957 - 966
Journal	British Journal of Pharmacology
Volume	155
Publication status	Published - 2008

Handle.net

Persistent link

Cite this

@article{869455f12842472ea3f3e10c4cc6ad2a,

title = "Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs",

author = "MJW McPate and RS. Duncan and JC Hancox and HJ Witchel",

year = "2008",

language = "English",

volume = "155",

pages = "957 -- 966",

journal = "British Journal of Pharmacology",

issn = "1476-5381",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs

AU - McPate, MJW

AU - Duncan, RS.

AU - Hancox, JC

AU - Witchel, HJ

PY - 2008

Y1 - 2008

M3 - Article (Academic Journal)

SN - 1476-5381

VL - 155

SP - 957

EP - 966

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

ER -